Australia is closely watching the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor medication , representing a potential advance in obesity treatment . Early research findings have demonstrated https://giant-bike-mountain-bike815836.wikibriefing.com/4680837/new_treatment_in_australia_a_promising_hope_for_obesity_management